pharmaceutical industry

• Extended version: Widespread drug shortages spur FDA policy revisions

  By Melissa Maleske  |  February 1, 2012

  Agency responds to executive order with new rules for drug makers

• 

  Widespread drug shortages spur FDA policy revisions

  By Melissa Maleske  |  February 1, 2012

  Agency responds to executive order with new rules for drug makers

• Extended interview: Sandra Leung, GC of Bristol-Myers Squibb

  By Ashley Post  |  December 1, 2011

  Leung talks in-depth about her position at the biopharmaceutical company.

• 

  GC Sandra Leung forms connections within the Bristol-Myers Squibb legal department

  By Ashley Post  |  December 1, 2011

  Leung is proudest of working with management to guide the company through past crises.

• 

  Supreme Court delivers big win to generic-drug makers

  By Ashley Post  |  September 1, 2011

  The high court's Pliva v. Mensing decision shields generic-medication companies from failure-to-warn claims.

• Final Dodd-Frank whistleblower rules reject internal reporting mandate

  By Melissa Maleske  |  August 1, 2011

  Final rules only incentivize employees to use corporate compliance programs.

• Labor: Employment Litigation in Three Major Industries

  By Paul E. Starkman  |  November 29, 2010

  What you should learn from recent investigations and suits.